Skip to content

Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography

Development of Novel Imaging Markers Predicting the Progression of Abdominal Aortic Aneurysm Using 3D Computed Tomography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04333641
Enrollment
323
Registered
2020-04-03
Start date
2020-04-03
Completion date
2023-04-17
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm (AAA)

Keywords

abdominal Aortic Aneurysm, CT, risk factor

Brief summary

Study purpose: This study will investigate anatomical factors associated with increased risk of major adverse aorta-related event and accelerated growth of abdominal aneurysm based on 3-dimensional analysis of CT images. Study design: a multicenter single-arm prospective observational study. Subject: patients with small abdominal aortic aneurysm with maximal diameter of 30-50 mm (n=323) Methods: Patients diagnosed with small AAA based on CT will be enrolled after considering inclusion and exclusion criteria and prospectively followed clinically and with CT at 1 year. Primary endpoint: Major adverse aorta-related events (death, aortic rupture, or aneurysm growth \>0.4 cm per year) at 1 year Secondary endpoints: 1) clinical events : death, aortic rupture, aneurysm growth \>0.4 cm per year, surgical or endovascular repair 2) Changes in CT parameters of aneurysm: diameter, volume, wall shear stress

Detailed description

Prospective single-arm multicenter registry

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- abdominal aortic aneurysm with maximum diameter of 30-50 mm

Exclusion criteria

* Age \<19 years * Serum Cr\> 1.5mg/dL or eGFR\<30 mL/min * Known allergic reactions to iodine contrast media * Women in pregnancy or women of childbearing age * Abdominal aortic aneurysms indicated for endovascular or surgical repair (symptomatic aneurysm or aneurysms with diameter \>5cm) * Saccular type aneurysm, infected or inflammatory aneurysm * Combined aortic dissection * Aneurysms associated with genetic or connective tissue diseases (Marfan syndrome, Shprintzen-Goldberg syndrome, Loeys-Dietz syndrome, Takayasu's arteritis, Behcet's disease) * Past history of surgical or endovascular repair of aorta * Any surgical or endovascular repair planned within 1 year * Life expectancy \< 1 year

Design outcomes

Primary

MeasureTime frameDescription
Major adverse aorta-related events1 yearComposite event of death, aortic rupture, or aneurysm growth \>0.4 cm per year

Secondary

MeasureTime frameDescription
Number of clinical events1 yeardeath, aortic rupture, aneurysm growth \>0.4 cm per year, surgical or endovascular repair
Change in CT parameter of aneurysm1 yeardiameter

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026